Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum SCYNEXIS Inc. SCYX

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor...

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:RE:RE:RE:BREXAFEMME - published User side effects

I'm disgusted too. What does $45MM get them, another quarter's worth of financing - maybe two? One would think that they'd do a financing AFTER their sNDA submittal. I guess more

RE:RE:RE:BREXAFEMME - published User side effects

I was going to sell at a loss, but decided to lower my average cost due to the discount. They will have $150M cash less Q1 spend. Probably trading at 70% current cash with an approved blockbuster more

RE:RE:BREXAFEMME - published User side effects

Yeah, I agree - worse sales than I had expected. They should get a pop however when they submit their supplemental NDA vis-a-vis rVVC in Q2. I'm still holding as their MC is hovering around more

RE:BREXAFEMME - published User side effects

The problem is Mario and Christine are spending with reckless abandon. We need a businessman to run the company not a doctor. Mario can raise money but it dilutes so value is not delivered. Burry more

BREXAFEMME - published User side effects

Join me by taking your action by contacting SCYX Investor Relations.   Today, I emailed Irina of SCYX - Investor Relations & recommended that Marco Taglietti, M.D.  launch more

RE:RE:RE:RE:RE:Stop Raising Dilutive Funds

Valued at cash again... well plus the long term debt. Expecting $20M burn as sales will take a while. Question is can they avoid another dilution with profits within next 3 or 4 quarters. The more

RE:RE:RE:RE:Stop Raising Dilutive Funds

Good presentation today. Also, good to hear that Burry bought almost 800K shares recently. Ibrexa will be a billion+ dollar drug within a few short years; it'll be quite a lucrative franchise more

RE:RE:RE:Stop Raising Dilutive Funds

Good volume. Back to breakeven. The payoff has taken a while but it'll be worth it. Very tight share structure.  rate and reply

RE:RE:RE:Stop Raising Dilutive Funds From the CEO BBs  rate and reply

RE:RE:Stop Raising Dilutive Funds

Good points. I have accumulated about my limit for these speculative buy mostly derisked value stocks. I plan to hold tight for 3 to 5 years and hope management will value the SP. Thanks!  rate and reply

RE:Stop Raising Dilutive Funds

There's no real capital raise here or dilution (only ~1.3mm shares). They filed the recent S3/prospectuses for a couple of purposes - because the original (written 3 years ago) was expiring, more

Stop Raising Dilutive Funds

Show some progress.before another capital raise. No focus on SP. Winning losers .. grrrrr.  rate and reply

RE:RE:RE:Drug just got approved! :)

Wow. These biopharma stocks are truly in show me stage for valuation. Great opportunity for those with high conviction (like me) to load up way more than you thought you could. Sales will start more

RE:Short Interest...

Shorters might have their way for now but once sales start to roll out then they will pay up. There cannot be a lot of downside to warrant taking on the risk of upside on positive roll out news. more

Short Interest...

Crazy high short interest here ( > 3.6mm shares short). I guess that's why the stock went down upon approval. I'm waiting for the EMEA contract to be finalized; with luck it'll more

RE:RE:Drug just got approved! :)

Yeah, I wasn't expecting this kind of reaction either. The next few weeks will tell the tale; the approval information needs to be absorbed. Based on the CC today, I inferred that an more

RE:Drug just got approved! :)

Seriously!? Approved and it goes down... Wtf  rate and reply

Drug just got approved! :) Cheers, JJ  rate and reply

RE:RE:2 Weeks Left...

Yeah, everyone's in waiting mode. I think the company has 24 hours to release material information - assuming they've received some. Personally, based on data the drug should be approved. more

RE:2 Weeks Left...

Wasn't the FDA supposed to deliver their verdict yesterday?  rate and reply